We are glad to announce, that MT-Medicals has closed a first VC deal with Primer Capital Venture Fund (Russiand Federation) to advance with anti-TB project of Target Medicals Group. The seed round was non-dilutively co-funded by Russan Ministry of Education to fascilitate an innovative drug discovery in treatment of drug-resistant tuberculosis.

https://primer-capital.com/en/partners/326/